In the Democratic Republic of Congo, a nation already fractured by conflict and displacement, health authorities have begun vaccinating frontline workers against an Ebola outbreak that has claimed nearly 2,744 lives — using a vaccine designed for a different strain of the virus. The Bundibugyo strain driving this crisis has no approved vaccine or treatment, yet officials have chosen imperfect action over paralysis, deploying Ervebo in a ring strategy outward from the epicenter of Ituri while clinical trials race to find a true answer. It is a moment that distills one of medicine's oldest dilem
DRC launches Ebola vaccination drive with untested vaccine amid deadly outbreak
As of Tuesday, 2,744 deaths recorded from 5,713 confirmed Ebola cases in DRC, with ongoing displacement and population movements fueling spread.
The vaccine being deployed was designed for a different strain
Mark
So they're vaccinating people with a vaccine that might not work against the strain that's actually killing them?
Mimi
That's the situation, yes. The Ervebo vaccine works against other Ebola strains, but this Bundibugyo variant is new enough that nobody knows if it will help. They're vaccinating anyway because the alternative—doing nothing—seems worse.
Luke
How much worse? Do we know if Ervebo offers any cross-protection, or is this completely untested?
Mimi
The source says effectiveness "has not been determined." That's the honest answer. They don't know.
Mark
And they're using 20,000 doses just to run trials?
Mimi
Right. Out of 70,000 doses approved by the WHO, 20,000 go to clinical trials. So they're testing while they vaccinate.
Luke
That's a lot of doses tied up in research when health workers are asking for more. How many health workers are we talking about?
Mimi
The source doesn't give a number for how many health workers need vaccination. It just says they're being prioritized and that workers are calling for more doses.
Mark
What's actually driving the spread if they have any vaccine at all?
Mimi
Insecurity, displacement, a health worker strike, and intense population movements. The outbreak is concentrated in Ituri province near Uganda, but it's spreading through a broken system.
Luke
And the death toll?
Mimi
2,744 deaths from 5,713 confirmed cases as of Tuesday. Nearly 50 percent.
Mark
Is that the highest rate they've seen?
Mimi
It's the deadliest outbreak the DRC has experienced, though the West Africa outbreak in 2014-2016 killed more total people—over 11,000—because it lasted longer and spread across three countries.
Luke
So the question is whether this one will follow that trajectory.
Mimi
Exactly. The WHO says it's on track to do so if control measures fail.
The Pulse
- With nearly 2,744 dead from 5,713 confirmed cases, the DRC is living through the deadliest Ebola outbreak in its history — and the virus is still accelerating.
- Armed conflict, mass displacement, and a health worker strike have shattered the containment infrastructure that any outbreak response depends upon.
- Officials are vaccinating frontline workers with Ervebo, a vaccine proven against other Ebola strains but untested against the Bundibugyo variant now spreading across the country.
- A ring vaccination strategy is pushing outward from Kisangani, attempting to build a firewall around Ituri before the virus can reach deeper into the population.
- The WHO has issued a stark warning: without rapid intervention, this outbreak could surpass the 2014–2016 West Africa epidemic that killed over 11,000 people — the deadliest on record.
In the Democratic Republic of Congo, a nation already fractured by conflict and displacement, health authorities have begun vaccinating frontline workers against an Ebola outbreak that has claimed nearly 2,744 lives — using a vaccine designed for a different strain of the virus. The Bundibugyo strain driving this crisis has no approved vaccine or treatment, yet officials have chosen imperfect action over paralysis, deploying Ervebo in a ring strategy outward from the epicenter of Ituri while clinical trials race to find a true answer. It is a moment that distills one of medicine's oldest dilemmas: whether to act with incomplete knowledge, or wait for certainty while the world burns.
The Democratic Republic of Congo has launched an Ebola vaccination campaign this week, deploying the Ervebo vaccine among frontline health workers in Kisangani and surrounding cities. The catch is significant: Ervebo was designed for other Ebola variants, and its effectiveness against the Bundibugyo strain now driving the outbreak remains unproven. No approved vaccine or treatment yet exists for this particular virus. Of the 70,000 WHO-approved doses, roughly 20,000 will be directed toward clinical trials rather than field deployment — a parallel effort to find a real answer while the outbreak continues to spread.
Health Minister Samuel Roger Kamba confirmed that more than 50,000 doses have arrived in the country. The campaign follows a ring strategy, vaccinating provinces surrounding Ituri — the outbreak's epicenter — and gradually moving inward. Health workers on the ground are already calling for more doses, a measure of how acute the crisis has become.
The numbers are staggering: 5,713 confirmed cases and 2,744 deaths, a fatality rate approaching 50 percent. This is already the worst Ebola outbreak the DRC has ever recorded. The virus is spreading through a landscape torn apart by armed conflict, mass displacement, and a strike among the very health workers meant to contain it — conditions that make the kind of coordinated response needed nearly impossible to sustain.
The WHO has warned that without swift intervention, this outbreak could surpass the 2014–2016 West Africa epidemic, which killed more than 11,000 people and took nearly three years to bring under control. The DRC's fractured infrastructure may allow the virus to move even faster. Faced with that prospect, public health officials have chosen imperfect action over inaction — vaccinating with a tool of uncertain effectiveness in hopes it offers some protection while science races to catch up with the crisis.
The Democratic Republic of Congo has begun vaccinating its frontline health workers against Ebola this week, but the vaccine being deployed was designed for a different strain of the virus. The shots going into arms in Kisangani and other cities are the Ervebo vaccine, which is licensed and proven effective against other Ebola variants. Against the Bundibugyo strain now ravaging the country, however, its power remains unknown. No approved vaccine or treatment exists yet for this particular virus. Clinical trials are underway to find one, and about 20,000 of the 70,000 doses the World Health Organization approved for the DRC will be used in those experiments rather than in the field.
Health Minister Samuel Roger Kamba announced that more than 50,000 doses have already arrived in the country. The vaccination campaign is moving outward from Kisangani in what officials call a "ring" strategy—vaccinating people in provinces surrounding Ituri, the epicenter of the outbreak, and gradually working inward toward the heart of the crisis. Health workers themselves are calling for more doses, a sign of how desperate the situation has become on the ground.
The numbers tell the story of an outbreak spiraling beyond control. As of Tuesday, the DRC had recorded 5,713 confirmed cases of Ebola and 2,744 deaths—a fatality rate that approaches 50 percent. This is already the deadliest Ebola outbreak the country has ever experienced. The virus is spreading through a landscape fractured by armed conflict, mass displacement, and a strike by health workers themselves. Population movements continue to carry the disease across borders and between communities, making containment nearly impossible.
The World Health Organization has warned that without rapid intervention, this outbreak is on track to eclipse the 2014-2016 West Africa epidemic, which killed more than 11,000 people across Guinea, Liberia, and Sierra Leone and remains the deadliest Ebola outbreak on record. That outbreak took nearly three years to bring under control. The conditions in the DRC—insecurity, displacement, the breakdown of health systems—are creating an environment where the virus can move faster and farther than it did in West Africa.
The decision to vaccinate with an unproven vaccine reflects the impossible calculus facing public health officials: do nothing and watch the outbreak accelerate, or deploy a tool of uncertain effectiveness in hopes it offers some protection. Health workers, who face the highest risk of infection, are the first to receive the shots. Whether the vaccine will slow the spread remains to be seen. The clinical trials running in parallel will eventually answer whether Ervebo works against Bundibugyo, but by then thousands more may have been infected. The outbreak is moving faster than the science can follow.
Notable Quotes
We will cover all the provinces that are around Ituri, moving in the ring towards the centre of the outbreak.— Health Minister Samuel Roger Kamba
Want the full story?
Read the original at Al Jazeera ↗
Health & Medicine